Oral immunosuppressants: oral cyclosporin vs topical betamethasone dipropionate
Number of participants with any adverse event (primary tolerability outcome) · people with hand eczema, continuously for 6 months, significant disability, inadequate response to conventional treatment, confirmation by…
Oral immunosuppressants: oral cyclosporin showed no clear difference in primary: adverse events ‐ at least 1 adverse event compared with topical betamethasone dipropionate (moderate certainty).
1 finding from 1 review
- RR 1.22 [0.8, 1.86]1 study · 55 participantsModerate